Maternal mumps antibodies in a cohort of children up to the age of 1 year

European Journal of Pediatrics

Volumn 171, Issue 8, 2012, Pages 1167-1173

  Leuridan, E ^a   Goeyvaerts, N ^a,b   Hens, N ^a,b   Hutse, V ^c   Van Damme, P ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b HASSELT UNIVERSITY   (Belgium)

^c SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

Author keywords

Maternal antibodies; Mumps; Vaccination

Indexed keywords

IMMUNOGLOBULIN G; MATERNAL ANTIBODY; MATERNAL MUMPS ANTIBODY; UNCLASSIFIED DRUG;

BIRTH WEIGHT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INNATE IMMUNITY; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; VACCINATION;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; BIOLOGICAL MARKERS; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; MEASLES-MUMPS-RUBELLA VACCINE; MODELS, STATISTICAL; MUMPS VIRUS; PREGNANCY; PROSPECTIVE STUDIES; TIME FACTORS; YOUNG ADULT;

EID: 84866042987     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/s00431-012-1691-y     Document Type: Review

References (44)

1. Caceres VM, Strebel PM, Sutter RW (2000) Factors determining prevalence of maternal antibody to measles virus throughout infancy: a review. ClinInfectDis 31:110-119 (Pubitemid 32268948)
2. Castilla J, Garcia Cenoz M, Barricarte A, Irisarri F, Nunez-Cordoba JM, Barricarte A (2007) Mumps outbreak in Navarre region, Spain, 2006-2007. Euro Surveillance 12:E070215-070211
3. Celko A, Burianova B, Fedova D, Koza J, Zikmundova V, Zikmund V, Stribrny J (1985) Transplacental antibodies. Part III: Maternal antibodies against polioviruses, M. parotitidis and M. parainfluenzae. J Hyg Epidemiol Microbiol Immunol 29:193-199 (Pubitemid 15095636)
4. Centers for Disease Control and Prevention (2010) Update: mumps outbreak-New York and New Jersey, June 2009-January 2010. MMWR Morb Mortal Wkly Rep 59:125-129
5. Cohen C, White JM, Savage EJ, Glynn JR, Choi Y, Andrews N, Brown D, Ramsay ME (2007) Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis 13:12-17 (Pubitemid 46057832)
6. Date AA, Kyaw MH, Rue AM, Klahn J, Obrecht L, Krohn T, Rowland J, Rubin S, Safranek TJ, Bellini WJ, Dayan GH (2008) Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population. J Infect Dis 197:1662-1668 (Pubitemid 351919629)
7. Dayan GH, Quinlisk MP, Parker AA, Barskey AE, Harris ML, Schwartz JM, Hunt K et al (2008) Recent resurgence of mumps in the United States. N Engl J Med 358:1580-1589 (Pubitemid 351519818)
8. deMoraesPinto MI, Almeida ACM, Kenj G, Filgueiras TE, Tobias W, Santos AMN, CarneiroSampaio MMS, Farhat CK, Milligan PJM, Johnson PM, Hart CA (1996) Placental transfer and maternally acquired neonatal IgG immunity in human immunodeficiency virus infection. J Infect Dis 173:1077-1084 (Pubitemid 26251448)
9. Desgrandchamps D, Schaad UB, Glaus J, Tusch G, Heininger U (2000) Seroprevalence of IgG antibodies against measles, mumps and rubella in Swiss children during the first 16 months of life. Schweiz Med Wochenschr 130:1479-1486
10. Gans H, DeHovitz R, Forghani B, Beeler J, Maldonado Y, Arvin AM (2003) Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life. Vaccine 21:3398-3405 (Pubitemid 36792094)
11. Gans H, Yasukawa L, Rinki M, DeHovitz R, Forghani B, Beeler J, Audet S, Maldonado Y, Arvin AM (2001) Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months. J Infect Dis 184:817-826 (Pubitemid 32881086)
12. Gotlieb-Stematsky T, Meron I, Modan M, Sayar Y, Leventon-Kriss S, Fogel A, Gurewitz R, Insler V (1983) Viral antibodies in maternal and cord sera. Med Microbiol Immunol (Berl) 172:67-74 (Pubitemid 13055260)
13. Hartter HK, Oyedele OI, Dietz K, Kreis S, Hoffman JP, Muller CP (2000) Placental transfer and decay of maternally acquired antimeasles antibodies in Nigerian children. Pediatr Infect Dis J 19:635-641 (Pubitemid 30469771)
14. Hodes D, Brunell PA (1970) Mumps antibody: placental transfer and disappearance during the first year of life. Pediatrics 45:99-101
15. Mumps Surveillance report 2010, Euvac.net (2011) http://ecdc.europa.eu/ en/publications/Publications/Forms/ECDC-DispForm. aspx?ID=751. Accessed 11 Oct. 2011
16. Hukic M, Ravlija J, Dedeic Ljubovic A, Moro A, Arapcic S, Muller CP et al (2011) Ongoing large mumps outbreak in the Federation of Bosnia and Herzegovina, Bosnia and Herzegovina, December 2010 to July 2011. Euro Surveill 16 (35)
17. Kaaijk P, van der Zeijst B, Boog M, Hoitink C (2008) Increased mumps incidence in the Netherlands: review on the possible role of vaccine strain and genotype. Euro Surveill 13
18. Karagiannis I, van Lier A, van Binnendijk R, Ruijs H, Ruijs H, Fanoy E, Conyn-Van Spaendonck MA, de Melker H, Hahne S (2008) Mumps in a community with low vaccination coverage in the Netherlands. Euro Surveillance 13:24
19. Kay D, Roche M, Atkinson J, Lamden K, Vivancos R (2011) Mumps outbreaks in four universities in the North West of England: prevention, detection and response. Vaccine 29:3883-3887
20. Kuzmanovska G, Polozhani A, Mikik V, Stavridis K, Aleksoski B, Cvetanovska Z, Binnendijk R, Bosevska G (2010) Mumps outbreak in the former Yugoslav Republic of Macedonia, January 2008-June 2009: epidemiology and control measures. Euro Surveillance 15:23
21. Lashkari HP, El Bashir H (2010) Immunisations among school leavers: is there a place for measles-mumps-rubella vaccine? Euro Surveillance 15:17
22. Le Baron CW, Beeler J, Sullivan BJ, Forghani B, Bi D, Beck C, Audet S, Gargiullo P (2007) Persistence of measles antibodies after 2 doses of measles vaccine in a postelimination environment. Arch Pediatr Adolesc Med 161:294-301 (Pubitemid 46364333)
23. Le Baron CW, Forghani B, Beck C, Brown C, Bi D, Cossen C, Sullivan BJ (2009) Persistence of mumps antibodies after 2 doses of measles-mumps-rubella vaccine. J Infect Dis 199:552-560
24. Leineweber B, Grote V, Schaad UB, Heininger U (2004) Transplacentally acquired immunoglobulin G antibodies against measles, mumps, rubelia and varicella-zoster virus in preterm and full term newborns. Pediatr Infect Dis J 23:361-363 (Pubitemid 38508894)
25. Leuridan E, Hens N, Hutse V, Aerts M, Van Damme P (2011) Kinetics of maternal antibodies against rubella and varicella in infants. Vaccine 29:2222-2226
26. Leuridan E, Hens N, Hutse V, Ieven M, Aerts M, Van Damme P (2010) Early waning of maternal measles antibodies in era of measles elimination: longitudinal study. British Medical Journal 340:c1626
27. Leuridan E, Van Damme P (2007) Passive transmission and persistence of naturally acquired or vaccine-induced maternal antibodies against measles in newborns. Vaccine 25:6296-6304 (Pubitemid 47090234)
28. Manikkavasagan G, Ramsay M (2009) Protecting infants against measles in England and Wales: a review. Arch Dis Child 94:681-685
29. Moraes-Pinto MI, Verhoeff F, Chimsuku L, Milligan PJ, Wesumperuma L, Broadhead RL, Brabin BJ, Johnson PM, Hart CA (1998) Placental antibody transfer: influence of maternal HIV infection and placental malaria. Arch Dis Child Fetal Neonatal Ed 79:F202-F205 (Pubitemid 28500677)
30. Nicoara C, Zach K, Trachsel D, Germann D, Matter L (1999) Decay of passively acquired maternal antibodies against measles, mumps, and rubella viruses. Clin Diagn Lab Immunol 6:868-871 (Pubitemid 29529980)
31. Okoko BJ, Wesumperuma LH, Hart AC (2001) Materno-foetal transfer of H. influenzae and pneumococcal antibodies is influenced by prematurity and low birth weight: implications for conjugate vaccine trials. Vaccine 20:647-650 (Pubitemid 34015805)
32. Okoko JB, Wesumperuma HL, Hart CA (2001) The influence of prematurity and low birthweight on transplacental antibody transfer in a rural West African population. Trop Med Int Health 6:529-534 (Pubitemid 32664635)
33. Oyedele OO, Odemuyiwa SO, Ammerlaan W, Muller CP, Adu FD (2005) Passive immunity to measles in the breastmilk and cord blood of some nigerian subjects. J Trop Pediatr 51:45-48 (Pubitemid 40394192)
34. Park DW, Nam MH, Kim JY, Kim HJ, Sohn JW, Cho Y, Song KJ, Kim MJ (2007) Mumps outbreak in a highly vaccinated school population: assessment of secondary vaccine failure using IgG avidity measurements. Vaccine 25:4665-4670 (Pubitemid 46813114)
35. Redd SC, King GE, Heath JL, Forghani B, Bellini WJ, Markowitz LE (2004) Comparison of vaccination with measles-mumpsrubella vaccine at 9, 12, and 15 months of age. J Infect Dis 189(Suppl 1):S116-S122 (Pubitemid 38639579)
36. Sato H, Albrecht P, Reynolds DW, Stagno S, Ennis FA (1979) Transfer of measles, mumps, and rubella antibodies from mother to infant. Its effect on measles, mumps, and rubella immunization. Am J Dis Child 133:1240-1243 (Pubitemid 10205400)
37. Sauerbrei A, Groh A, Bischoff A, Prager J, Wutzler P (2002) Antibodies against vaccine-preventable diseases in pregnant women and their offspring in the eastern part of Germany. Med Microbiol Immunol (Berl) 190:167-172 (Pubitemid 34230746)
38. Siegrist CA (2001) Neonatal and early life vaccinology. Vaccine 19:3331-3346
39. Singh J, Khare S, Prabha S, Chandra R, Jain DC, Bhatia R, Sokhey J (1998) Transplacental transfer of measles antibody in Delhi. Indian Pediatr 35:1187-1191
40. Theeten H, Hutse V, Hens N, Yavuz Y, Hoppenbrouwers K, Beutels P, Vranckx R, Van Damme P (2011) Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium. Epidemiol Infect 139:494-504
41. Vandermeulen C, Mathieu R, Leroux-Roels G, Van Damme P, Hoppenbrouwers K (2007) Long-term persistence of antibodies after one or two doses of MMR-vaccine. Vaccine 25:6672-6676 (Pubitemid 47332734)
42. Vandermeulen C, Roelants M, Vermoere M, Roseeuw K, Goubau P, Hoppenbrouwers K (2004) Outbreak of mumps in a vaccinated child population: a question of vaccine failure? Vaccine 22:2713-2716 (Pubitemid 38900645)
43. Verbeke M (2000) Linear Mixed Models for Longitudinal Data. Springer Verlag, New York
44. Wesumperuma HL, Perera AJ, Pharoah POD, Hart CA (1999) The influence of prematurity and low birthweight on transplacental antibody transfer in Sri Lanka. Ann Trop Med Parasitol 93:169-177 (Pubitemid 29358539)